Bolus Calculator and Wireless Communication With Blood Glucose Meter in Management of Type 1 Diabetes Mellitus (T1DM).
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Bolus calculator (BC) is one of the advanced functions in modern insulin pumps (CSII)models. Together with wireless communication with blood glucose meter potentially facilitates achieving the target post prandial glucose levels. In this RCT authors assessed whether use of wireless communication between compatible devices: MiniMed insulin pump and blood glucose meter Contour Link (CL), Bayer results in more frequently bolus calculator using and what is the impact of exerting this tool on metabolic control in type 1 diabetic patients.
| Condition | Intervention |
|---|---|
|
Type 1 Diabetes Mellitus |
Device: CSII+BC+CL Device: CSII+BC |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | The Impact of Insulin Pump Bolus Calculator and Wireless Communication With Blood Glucose Meter on Metabolic Control in Children With Type 1 Diabetes Mellitus - Randomised Control Trial |
- HbA1c (Glycated hemoglobin) [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
- Post- prandial glycaemia [ Time Frame: 2 hours after the meals ] [ Designated as safety issue: Yes ]Post- prandial glycaemia is express as a mean post- prandial glycaemia counted after the meal consumed between 1- 6 pm during subsequently 7- 10 days
- Treatment satisfaction [ Time Frame: 3 months ] [ Designated as safety issue: No ]Simple questions regarded treatment satisfaction and wish to continuation.
- Hypoglycaemia episodes and severe hypoglycaemia events [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]Hypoglycaemia defined as glycaemia below 70 mg/dl and, separately, glycaemia below 50 mg/dl.
- Frequency of self- blood glucose monitoring [ Time Frame: 3 months ] [ Designated as safety issue: No ]Number of self- blood glucose monitoring per day
- Hyperglycaemic episodes [ Time Frame: 3 months ] [ Designated as safety issue: No ]Hyperglycaemia defined as glycaemia above 180 mg/dl
- Frequency of meal boluses [ Time Frame: 3 months ] [ Designated as safety issue: No ]Number of meal boluses per day
- Frequency of bolus calculator using [ Time Frame: 3 months ] [ Designated as safety issue: No ]Number of bolus calculator use per day
- Total daily dose of insulin [ Time Frame: 3 months ] [ Designated as safety issue: No ]Total daily dose of insulin express as jm/kg/d
- Body mass index- standard deviation (BMI- sds) [ Time Frame: 3 months ] [ Designated as safety issue: No ]Body mass index- sds
| Enrollment: | 156 |
| Study Start Date: | January 2011 |
| Study Completion Date: | July 2012 |
| Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: CSII+BC+CL
Patients using insulin pump (CSII) bolus calculator (BC) wirelessly connected with blood glucose meter Contour Link (CL)
|
Device: CSII+BC+CL
Insulin pump bolus calculator wirelessly communicated with blood glucose meter (Contour Link)
Other Name: Insulin pump, bolus calculator, bolus Wizard, Contour Link
|
|
Experimental: CSII+BC
Patients using insulin pump (CSII) bolus calculator (BC) without wireless connection with blood glucose meter (CL)
|
Device: CSII+BC
Insulin pump bolus calculator without wireless communication with blood glucose meter (Contour Link)
Other Name: Insulin pump, bolus calculator, bolus Wizard
|
|
No Intervention: CSII (insulin pump only)
Patients using insulin pump (CSII) without BC and connection with CL
|
Detailed Description:
In this RCT 156 patients were randomly assigned to one of the 3 arms: group A- subjects using insulin pump bolus calculator wirelessly connected with blood glucose meter, group B- subjects using insulin pump bolus calculator without wireless communication with blood glucose meter or group C- insulin pump, without bolus calculator function. We compared the glycated hemoglobin levels and post- prandial hypoglycaemia after 3 months of observation between the groups. We also assessed secondary endpoints (mentioned above).
Patients were estimated at three time points: at the beginning, after 6 weeks and after 3 months of intervention. Investigators performed computer reports at each visit, with Medtronic CareLink Pro software.
Eligibility| Ages Eligible for Study: | 7 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 7- 18 years old
- type 1 diabetes mellitus for over 1 year
- treatment with insulin pump with bolus calculator function
- HbA1c < 10%
- expressed written informed consent
Exclusion Criteria:
- recall the consent
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Medical University of Warsaw |
| ClinicalTrials.gov Identifier: | NCT01677546 History of Changes |
| Other Study ID Numbers: | Bolus-calculator |
| Study First Received: | August 22, 2012 |
| Last Updated: | August 29, 2012 |
| Health Authority: | Poland: Ethics Committee |
Keywords provided by Medical University of Warsaw:
|
diabetes insulin pump bolus calculator Contour Link |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune Diseases |
Immune System Diseases Insulin Hypoglycemic Agents Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 21, 2013